AI reads brain scans to spot hidden cancer mutations
NCT ID NCT07373951
First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study looks at whether artificial intelligence can analyze routine brain MRI scans to predict specific genetic changes (EGFR or ALK) in non-small cell lung cancer that has spread to the brain. Researchers will use scans from 380 patients across multiple hospitals to train and test the AI model. The goal is to see if this noninvasive method can help guide treatment without needing a brain biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.